Vascular endothelial growth factor (VEGF) fails to predict response to neoadjuvant chemotherapy for primary breast cancer.

Podobné jednotky

• Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
  Autor: Tolaney, Sara M., a další
  Vydáno: (2017)
• Outcome after neoadjuvant chemotherapy in Asian breast cancer patients
  Autor: Lim, L.Y., a další
  Vydáno: (2016)
• The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
  Autor: Abraham, JE, a další
  Vydáno: (2024)
• Serum vascular endothelial growth factor (vegf) as a biomarker of lupus nephritis
  Autor: Iberahim, Rahimah
  Vydáno: (2013)
• Incidence of chemotherapy-induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy
  Autor: Ngidi, S, a další
  Vydáno: (2017)